The administration has been discussing plans to expand SAVE since the first months of Trump’s presidency. In May, US ...

Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT ...

Bank of Japan policymakers saw a growing case to raise interest rates in the near term, with some calling for the need to ...

I’m a Durango resident, mechanical engineer, and daily user of the Camino del Rio and 12th Street crossing. I walk or bike through this PHB/HAWK multiple times a day – often four or more – and it ...

AI-enabled search is shifting discovery from keyword matching to intent and context. This means marketers must now structure ...

Are you ready to take your manufacturing operations to the next level? Check out the executive summary from our insightful ...

Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify ...

The DOT study's control groups, i.e. intersections without daylighting, were also "too distant or dissimilar" in some cases, ...

In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...

Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CET IMA402 and IMA401 TCR Bispecifics ...

The double-digit increase is projected to keep growing this year and, according to median motion resolution times gathered in ...

Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...